Symbols / OSRH Stock $0.69 +16.43% OSR Holdings, Inc.

Healthcare • Biotechnology • United States • NCM
OSRH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Kuk Hyoun Hwang
Exch · Country NCM · United States
Market Cap 22.96M
Enterprise Value 75.06M
Income -18.01M
Sales 2.91M
FCF (ttm) 9.38M
Book/sh 2.92
Cash/sh 0.05
Employees 22
Insider 10d —
IPO Mar 21, 2023
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 7.90
P/B 0.24
P/C —
EV/EBITDA -8.31
EV/Sales 25.83
Quick Ratio 0.12
Current Ratio 0.16
Debt/Eq 3.47
LT Debt/Eq —
EPS (ttm) -0.92
EPS next Y —
EPS Growth —
Revenue Growth -58.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-31
Earnings (prior) 2026-03-31
ROA -6.61%
ROE -20.03%
ROIC —
Gross Margin 19.14%
Oper. Margin -16.75%
Profit Margin 0.00%
Shs Outstand 33.12M
Shs Float 15.28M
Insider Own 40.72%
Instit Own 0.52%
Short Float 1.93%
Short Ratio 0.19
Short Interest 228.15K
52W High 1.79
vs 52W High -61.28%
52W Low 0.38
vs 52W Low 82.37%
Beta 0.59
Impl. Vol. —
Rel Volume 2.28
Avg Volume 813.94K
Volume 1.85M
Target (mean) $10.00
Tgt Median $10.00
Tgt Low $10.00
Tgt High $10.00
# Analysts 1
Recom None
Prev Close $0.60
Price $0.69
Change 16.43%
About

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$10.00
Mean price target
2. Current target
$0.69
Latest analyst target
3. DCF / Fair value
$5.10
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.69
Low
$10.00
High
$10.00
Mean
$10.00
News
RSS: Latest OSRH news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2.91
-17.69%
3.53
0.00
0.00
Operating Revenue
2.91
-17.69%
3.53
0.00
0.00
Cost Of Revenue
2.31
-14.94%
2.72
+7.28%
2.53
0.00
Reconciled Cost Of Revenue
2.31
-14.98%
2.72
+8.09%
2.52
0.00
Gross Profit
0.59
-26.91%
0.81
-11.96%
0.92
0.00
Operating Expense
18.93
+51.39%
12.50
+582.99%
1.83
+194.65%
0.62
Research And Development
0.32
+97.60%
0.16
-35.82%
0.25
0.00
Selling General And Administration
9.19
+262.41%
2.54
+38.53%
1.83
+213.09%
0.58
Selling And Marketing Expense
0.00
-100.00%
0.00
-59.93%
0.01
0.00
General And Administrative Expense
9.19
+262.80%
2.53
+38.38%
1.83
+213.09%
0.58
Salaries And Wages
1.97
+80.10%
1.09
+5.31%
1.04
+159.03%
0.40
Other Gand A
7.10
+441.53%
1.31
-28.33%
1.83
+905.66%
0.18
Other Operating Expenses
0.04
+8.81%
0.03
+48.55%
0.02
+408.77%
0.00
Total Expenses
21.24
+39.54%
15.22
+731.51%
1.83
+194.65%
0.62
Operating Income
-18.34
-56.82%
-11.69
-538.67%
-1.83
-194.65%
-0.62
Total Operating Income As Reported
-18.34
-56.82%
-11.69
-538.67%
-1.83
-194.65%
-0.62
EBITDA
-19.08
-787.23%
-2.15
-327.62%
0.94
-14.32%
1.10
Normalized EBITDA
-19.08
-787.23%
-2.15
-327.62%
0.94
+259.85%
-0.59
Reconciled Depreciation
9.31
-3.96%
9.69
-0.25%
9.71
+41688.99%
0.02
EBIT
-28.38
-139.69%
-11.84
-1353.59%
0.94
-12.47%
1.08
Total Unusual Items
—
—
-0.41
-124.42%
1.69
Total Unusual Items Excluding Goodwill
—
—
-0.41
-124.42%
1.69
Special Income Charges
—
—
-0.31
-117.79%
1.75
Impairment Of Capital Assets
—
—
0.31
0.00
Write Off
—
—
0.00
-100.00%
0.08
Net Income
-18.01
-74.37%
-10.33
-2658.05%
0.40
-62.09%
1.06
Pretax Income
-28.89
-142.91%
-11.89
-1359.03%
0.94
-11.30%
1.06
Net Non Operating Interest Income Expense
-0.44
-1372.36%
-0.03
-101.08%
2.78
+22721.61%
-0.01
Interest Expense Non Operating
0.51
+886.06%
0.05
0.00
-100.00%
0.01
Net Interest Income
-0.44
-1372.36%
-0.03
-101.08%
2.78
+22721.61%
-0.01
Interest Expense
0.51
+886.06%
0.05
0.00
-100.00%
0.01
Interest Income Non Operating
0.06
+200.00%
0.02
-99.23%
2.78
+141761.86%
0.00
Interest Income
0.06
+200.00%
0.02
-99.23%
2.78
+141761.86%
0.00
Other Income Expense
-10.11
-5831.70%
-0.17
+58.12%
-0.41
-123.96%
1.70
Other Non Operating Income Expenses
-10.11
-5831.70%
-0.17
-2689.92%
0.01
+26.84%
0.01
Gain On Sale Of Security
—
—
-0.10
-85.04%
-0.06
Tax Provision
-1.83
-17.01%
-1.56
-389.15%
0.54
0.00
Tax Rate For Calcs
0.00
-51.83%
0.00
-37.39%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-27.06
-161.97%
-10.33
-2658.05%
0.40
-62.09%
1.06
Net Income From Continuing Operation Net Minority Interest
-18.01
-74.37%
-10.33
-2658.05%
0.40
-62.09%
1.06
Net Income From Continuing And Discontinued Operation
-18.01
-74.37%
-10.33
-2658.05%
0.40
-62.09%
1.06
Net Income Continuous Operations
-27.06
-161.97%
-10.33
-2658.05%
0.40
-62.09%
1.06
Minority Interests
9.05
0.00
0.00
0.00
Normalized Income
-18.01
-74.37%
-10.33
-2658.05%
0.40
+164.26%
-0.63
Net Income Common Stockholders
-18.01
-74.37%
-10.33
-2658.05%
0.40
-62.09%
1.06
Diluted EPS
—
-0.54
-385.97%
0.19
-62.09%
0.49
Basic EPS
—
-0.54
-385.97%
0.19
-62.09%
0.49
Basic Average Shares
—
19.28
+794.52%
2.15
+0.00%
2.15
Diluted Average Shares
—
19.28
+794.52%
2.15
+0.00%
2.15
Diluted NI Availto Com Stockholders
-18.01
-74.37%
-10.33
-2658.05%
0.40
-62.09%
1.06
Amortization
9.30
-3.45%
9.63
+0.82%
9.55
0.00
Amortization Of Intangibles Income Statement
9.30
-3.45%
9.63
+0.82%
9.55
0.00
Depreciation Amortization Depletion Income Statement
9.31
-3.97%
9.69
-0.06%
9.70
+41612.79%
0.02
Depreciation And Amortization In Income Statement
9.31
-3.97%
9.69
-0.06%
9.70
+41612.79%
0.02
Depreciation Income Statement
0.01
-87.99%
0.06
-58.06%
0.14
+520.96%
0.02
Gain On Sale Of PPE
—
—
0.00
-99.94%
1.83
Insurance And Claims
0.02
+28.79%
0.01
-36.85%
0.02
+1830.75%
0.00
Other Taxes
0.03
+46.92%
0.02
+9.06%
0.02
+142.36%
0.01
Provision For Doubtful Accounts
0.04
-26.77%
0.06
+63.47%
0.04
0.00
Rent And Landing Fees
0.10
-14.05%
0.11
+393.68%
0.02
+6884.61%
0.00
Rent Expense Supplemental
0.10
-14.05%
0.11
+393.68%
0.02
+6884.61%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
171.24
-2.28%
175.24
+378.43%
36.63
-69.67%
120.76
Current Assets
2.82
+21.08%
2.33
+10181.92%
0.02
-99.49%
4.42
Cash Cash Equivalents And Short Term Investments
1.70
+397.82%
0.34
+2115.08%
0.02
-99.45%
2.82
Cash And Cash Equivalents
1.70
+397.82%
0.34
+2115.08%
0.02
-99.45%
2.82
Other Short Term Investments
0.00
0.00
0.00
0.00
Receivables
0.60
-35.85%
0.93
0.00
-100.00%
0.51
Accounts Receivable
0.32
-64.70%
0.90
-99.94%
1,475.40
+396090.31%
0.37
Gross Accounts Receivable
0.38
-60.73%
0.97
-99.94%
1,520.89
+408306.43%
0.37
Allowance For Doubtful Accounts Receivable
-0.06
+7.71%
-0.07
+99.85%
-45.49
0.00
Other Receivables
0.07
+147.86%
0.03
-99.96%
68.14
+55723.38%
0.12
Taxes Receivable
—
—
6.71
+58184.23%
0.01
Loans Receivable
0.21
0.00
0.00
—
Inventory
0.20
-78.70%
0.92
-99.95%
1,802.61
+166983.36%
1.08
Finished Goods
0.20
-78.70%
0.92
-99.95%
1,802.61
+166983.36%
1.08
Prepaid Assets
0.32
+148.85%
0.13
-99.92%
160.28
+981990.92%
0.02
Other Current Assets
-0.00
-200.00%
0.00
-99.99%
0.01
—
Total Non Current Assets
168.42
-2.60%
172.91
+372.37%
36.61
-68.54%
116.34
Net PPE
0.25
+146.05%
0.10
-99.96%
235.44
+63257.85%
0.37
Gross PPE
0.54
+38.59%
0.39
-99.96%
897.98
+161397.68%
0.56
Accumulated Depreciation
-0.29
-0.55%
-0.29
+99.96%
-662.54
-359131.86%
-0.18
Properties
—
—
0.00
0.00
Buildings And Improvements
—
—
328.81
+112418.45%
0.29
Machinery Furniture Equipment
0.44
+62.36%
0.27
-99.95%
500.90
+237322.59%
0.21
Construction In Progress
0.02
+4.35%
0.02
-99.94%
34.92
+65993.76%
0.05
Other Properties
0.08
-17.30%
0.10
-99.70%
33.35
—
Goodwill And Other Intangible Assets
167.41
-2.90%
172.41
-99.94%
278,365.58
+240452.42%
115.72
Goodwill
24.95
+2.45%
24.35
-99.95%
47,516.59
+391597.68%
12.13
Other Intangible Assets
142.46
-3.78%
148.06
-99.94%
230,848.99
+222752.23%
103.59
Investments And Advances
0.00
+2.48%
0.00
-99.99%
7.95
+150210.40%
0.01
Non Current Deferred Assets
0.20
+117.71%
0.09
-99.91%
107.39
+421973.37%
0.03
Non Current Deferred Taxes Assets
0.20
+117.71%
0.09
-99.91%
107.39
+421973.37%
0.03
Other Non Current Assets
—
0.00
-100.00%
36.61
+3603190936.98%
0.00
Total Liabilities Net Minority Interest
44.20
+37.99%
32.03
+679.68%
4.11
-81.03%
21.66
Current Liabilities
17.17
+395.65%
3.46
+69.91%
2.04
-65.22%
5.86
Payables And Accrued Expenses
9.27
+502.60%
1.54
-24.50%
2.04
-55.39%
4.57
Payables
8.32
+670.66%
1.08
-47.06%
2.04
-52.15%
4.26
Accounts Payable
7.83
+625.84%
1.08
-0.28%
1.08
-74.58%
4.26
Current Accrued Expenses
0.96
+108.29%
0.46
-99.92%
558.55
+180901.58%
0.31
Employee Benefits
—
—
2.44
0.00
Pensionand Other Post Retirement Benefit Plans Current
—
—
27.80
+194229.94%
0.01
Total Tax Payable
0.49
+190273.33%
0.00
-99.97%
0.88
+20598.89%
0.00
Income Tax Payable
0.49
+190273.33%
0.00
-99.95%
0.52
+12175.43%
0.00
Current Debt And Capital Lease Obligation
4.39
+138.01%
1.84
-99.70%
605.83
+50936.88%
1.19
Current Debt
4.34
+141.32%
1.80
-99.64%
500.00
+43854.34%
1.14
Other Current Borrowings
2.32
+29.10%
1.80
-99.64%
500.00
+54648.93%
0.91
Current Capital Lease Obligation
0.05
+4.96%
0.04
-99.96%
105.83
+213706.60%
0.05
Other Current Liabilities
3.50
+4289.26%
0.08
-99.90%
78.34
+86304.80%
0.09
Total Non Current Liabilities Net Minority Interest
27.04
-5.36%
28.57
+1280.10%
2.07
-86.90%
15.80
Long Term Debt And Capital Lease Obligation
0.01
-97.64%
0.53
-99.91%
561.66
+150200.93%
0.37
Long Term Debt
—
0.50
-99.89%
460.00
+362986.61%
0.13
Long Term Capital Lease Obligation
0.01
-62.39%
0.03
-99.97%
101.66
+41057.39%
0.25
Non Current Pension And Other Postretirement Benefit Plans
—
—
2.44
0.00
Non Current Deferred Liabilities
27.02
-3.62%
28.04
+1254.37%
2.07
-86.58%
15.42
Non Current Deferred Taxes Liabilities
27.02
-3.62%
28.04
-99.94%
43,328.01
+280795.29%
15.42
Other Non Current Liabilities
0.00
+2.48%
0.00
—
—
Stockholders Equity
77.64
-45.79%
143.21
+340.38%
32.52
-67.18%
99.10
Common Stock Equity
77.64
-45.79%
143.21
+340.38%
32.52
-67.18%
99.10
Capital Stock
0.00
+1131.48%
0.00
-100.00%
36.43
+692.70%
4.60
Common Stock
0.00
+1131.48%
0.00
-100.00%
36.43
+692.70%
4.60
Preferred Stock
—
0.00
0.00
—
Share Issued
26.60
+37.98%
19.28
+0.00%
19.28
+0.00%
19.28
Ordinary Shares Number
26.60
+37.98%
19.28
+0.00%
19.28
+0.00%
19.28
Additional Paid In Capital
110.97
-31.76%
162.61
0.00
-100.00%
94.45
Retained Earnings
-37.17
-93.87%
-19.17
-390.74%
-3.91
-7456.36%
0.05
Gains Losses Not Affecting Retained Earnings
3.84
+1801.91%
-0.23
-100.13%
168.94
0.00
Minority Interest
49.40
0.00
0.00
0.00
Other Equity Adjustments
3.84
+1801.91%
-0.23
-100.13%
168.94
—
Total Equity Gross Minority Interest
127.04
-11.29%
143.21
+340.38%
32.52
-67.18%
99.10
Total Capitalization
77.64
-45.98%
143.71
+341.91%
32.52
-67.23%
99.23
Working Capital
-14.35
-1162.27%
-1.14
+43.61%
-2.02
-39.67%
-1.44
Invested Capital
81.98
-43.66%
145.51
+347.44%
32.52
-67.60%
100.36
Total Debt
4.40
+85.34%
2.38
-99.80%
1,167.49
+74703.86%
1.56
Net Debt
2.64
+35.13%
1.96
-99.26%
263.46
—
Capital Lease Obligations
0.06
-23.81%
0.08
-99.96%
207.49
+69879.90%
0.30
Net Tangible Assets
-89.78
-207.43%
-29.20
-189.80%
32.52
+295.65%
-16.62
Tangible Book Value
-89.78
-207.43%
-29.20
-189.80%
32.52
+295.65%
-16.62
Available For Sale Securities
0.00
+2.48%
0.00
-99.99%
7.95
+150210.40%
0.01
Current Notes Payable
2.02
0.00
0.00
—
Duefrom Related Parties Current
—
0.30
0.00
—
Dueto Related Parties Current
—
0.07
+0.00%
0.07
—
Investmentin Financial Assets
0.00
+2.48%
0.00
-99.99%
7.95
+150210.40%
0.01
Line Of Credit
—
—
0.00
-100.00%
0.22
Non Current Note Receivables
0.56
+81.14%
0.31
-99.93%
440.42
+201462.88%
0.22
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.33
-134.01%
-1.85
-125.89%
-0.82
-58.58%
-0.52
Cash Flow From Continuing Operating Activities
-4.33
-134.01%
-1.85
-125.89%
-0.82
-58.58%
-0.52
Net Income From Continuing Operations
-27.06
-161.97%
-10.33
-2658.05%
0.40
-62.08%
1.06
Depreciation Amortization Depletion
9.31
-3.96%
9.69
-0.25%
9.71
+41688.99%
0.02
Depreciation
0.01
+23.20%
0.01
-92.35%
0.08
+231.55%
0.02
Amortization Cash Flow
9.30
-3.98%
9.68
+0.48%
9.64
0.00
Depreciation And Amortization
9.31
-3.96%
9.69
-0.25%
9.71
+41688.99%
0.02
Amortization Of Intangibles
9.30
-3.98%
9.68
+0.48%
9.64
0.00
Other Non Cash Items
12.05
+7705.68%
0.15
+105.56%
-2.78
-23375.35%
0.01
Pension And Employee Benefit Expense
—
—
0.07
0.00
Provisionand Write Offof Assets
—
—
0.03
0.00
Asset Impairment Charge
0.03
-52.72%
0.07
-77.36%
0.31
+303.42%
0.08
Deferred Tax
-1.83
-17.01%
-1.56
-61673.71%
0.00
+101.75%
-0.15
Deferred Income Tax
-1.83
-17.01%
-1.56
-61673.71%
0.00
+101.75%
-0.15
Operating Gains Losses
0.03
-83.61%
0.17
+17.52%
0.15
+108.02%
-1.82
Unrealized Gain Loss On Investment Securities
1.44
0.00
—
—
Net Foreign Currency Exchange Gain Loss
0.03
-83.40%
0.17
+123.78%
0.08
+782.26%
0.01
Gain Loss On Sale Of PPE
0.00
-100.00%
0.00
+304.18%
-0.00
0.00
Change In Working Capital
1.71
+4063.69%
-0.04
-102.77%
1.55
+1057.32%
0.13
Change In Receivables
0.57
+550.15%
0.09
+111.78%
-0.75
-18155.92%
0.00
Change In Inventory
0.76
+149.91%
0.31
+192.12%
-0.33
0.00
Change In Prepaid Assets
—
-0.08
-1038.39%
-0.01
—
Change In Payables And Accrued Expense
0.12
+133.77%
-0.36
-122.78%
1.56
+1528.10%
0.10
Change In Accrued Expense
0.48
+13952.03%
0.00
—
—
Change In Payable
-0.36
+0.62%
-0.36
-123.00%
1.56
+1528.10%
0.10
Change In Account Payable
-0.51
-48.31%
-0.34
-133.23%
1.04
—
Change In Other Current Assets
0.35
+2367.35%
-0.02
+70.64%
-0.05
-852.99%
-0.01
Change In Other Current Liabilities
-0.10
-52.15%
-0.07
-142.56%
-0.03
-167.95%
0.04
Investing Cash Flow
-2.64
-624.81%
0.50
+101.49%
-33.83
-1876.81%
-1.71
Cash Flow From Continuing Investing Activities
-2.64
-624.81%
0.50
+101.49%
-33.83
-1876.81%
-1.71
Net PPE Purchase And Sale
0.00
-83.57%
0.01
+213.15%
-0.01
+92.90%
-0.08
Purchase Of PPE
—
—
-0.01
+88.53%
-0.08
Sale Of PPE
0.00
-83.57%
0.01
+84.26%
0.00
0.00
Capital Expenditure
-0.18
—
-0.02
+78.92%
-0.08
Net Investment Purchase And Sale
-0.43
0.00
-100.00%
35.82
+1148.71%
-3.42
Purchase Of Investment
-0.43
0.00
+100.00%
-0.18
+94.73%
-3.42
Sale Of Investment
—
36.23
+0.66%
36.00
—
Net Business Purchase And Sale
1.22
0.00
0.00
-100.00%
1.78
Net Intangibles Purchase And Sale
-0.18
0.00
+100.00%
-0.01
0.00
Purchase Of Intangibles
-0.18
0.00
+100.00%
-0.01
0.00
Net Other Investing Changes
-3.26
-755.28%
0.50
+100.71%
-70.21
—
Financing Cash Flow
8.37
+606.57%
1.18
-96.57%
34.54
+632.46%
4.72
Cash Flow From Continuing Financing Activities
8.37
+606.57%
1.18
-96.57%
34.54
+632.46%
4.72
Net Issuance Payments Of Debt
3.57
+201.58%
1.18
+198.69%
-1.20
-212.60%
1.07
Issuance Of Debt
5.24
+177.35%
1.89
0.00
-100.00%
1.25
Repayment Of Debt
-1.67
-136.61%
-0.70
+41.29%
-1.20
-563.85%
-0.18
Long Term Debt Issuance
1.11
+367.16%
0.24
-78.87%
1.12
-10.16%
1.25
Long Term Debt Payments
-0.51
-944.33%
-0.05
+89.86%
-0.49
-168.74%
-0.18
Net Long Term Debt Issuance
0.59
+215.50%
0.19
-70.44%
0.63
-40.50%
1.07
Short Term Debt Issuance
4.13
+150.15%
1.65
0.00
0.00
Short Term Debt Payments
-1.15
-75.90%
-0.66
+45.40%
-1.20
0.00
Net Short Term Debt Issuance
2.98
+198.96%
1.00
+183.08%
-1.20
0.00
Net Common Stock Issuance
4.80
0.00
-100.00%
37.13
+917.34%
3.65
Common Stock Payments
—
-36.23
-0.66%
-36.00
—
Repurchase Of Capital Stock
—
-36.23
-0.66%
-36.00
—
Net Other Financing Charges
—
—
-1.39
—
Changes In Cash
1.40
+964.95%
-0.16
-48.08%
-0.11
-104.38%
2.49
Effect Of Exchange Rate Changes
-0.04
-3.45%
-0.04
-19.60%
-0.03
-49.37%
-0.02
Beginning Cash Position
0.34
-36.78%
0.54
+333.90%
0.12
-64.35%
0.35
End Cash Position
1.70
+397.82%
0.34
+2115.08%
0.02
-99.45%
2.82
Free Cash Flow
-4.50
-143.55%
-1.85
-125.89%
-0.82
-37.91%
-0.59
Interest Paid Supplemental Data
0.51
+838.64%
0.05
—
—
Income Tax Paid Supplemental Data
0.15
+938.52%
0.01
0.00
—
Change In Income Tax Payable
0.15
+1138.52%
-0.01
-102.82%
0.52
—
Change In Tax Payable
0.15
+1138.52%
-0.01
-102.82%
0.52
—
Common Stock Issuance
4.80
0.00
-100.00%
73.13
+1903.56%
3.65
Interest Paid CFO
—
—
-0.05
-332.81%
-0.01
Interest Received CFI
—
0.46
-18.92%
0.56
—
Interest Received CFO
—
—
0.03
+5275.61%
0.00
Issuance Of Capital Stock
4.80
0.00
-100.00%
73.13
+1903.56%
3.65
Sale Of Business
1.22
0.00
0.00
-100.00%
1.78
Taxes Refund Paid
—
—
-0.01
-109.59%
0.15
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category